IPP Bureau

Glenmark sets GHG emission targets for FY2035
Glenmark sets GHG emission targets for FY2035

By IPP Bureau - June 01, 2023

The target boundary includes biogenic land?related emissions and removals from bioenergy feedstock

HMD supplied 1.75 billion syringes of the total 13.3 billion COVID 19 vaccines administered globally
HMD supplied 1.75 billion syringes of the total 13.3 billion COVID 19 vaccines administered globally

By IPP Bureau - June 01, 2023

HMD had supplied 921.7 million syringes to the Government of India to facilitate over 2.2 billion Vaccination in India till date

Synexa Joins CEPI in advancing global epidemic preparedness and response
Synexa Joins CEPI in advancing global epidemic preparedness and response

By IPP Bureau - May 31, 2023

Synexa joins CEPI’s esteemed Central Lab Network to improve global epidemic preparedness

Janssen Tremfya excels as psoriasis treatment, outshining IL-17s, says GlobalData
Janssen Tremfya excels as psoriasis treatment, outshining IL-17s, says GlobalData

By IPP Bureau - May 31, 2023

The drug exhibited greater treatment persistence and control of moderate-to-severe PsO symptoms compared to secukinumab and ixekizumab

Concept Medical gets 4th IDE approval from USFDA
Concept Medical gets 4th IDE approval from USFDA

By IPP Bureau - May 31, 2023

For the treatment of Superficial Femoral Artery

PharmaLytica returns to Hyderabad
PharmaLytica returns to Hyderabad

By IPP Bureau - May 31, 2023

With over 150 leading companies, 300+ topline brands and knowledge-led conference sessions, the event is set to make a grand return to the South

Capnopharm receives CE certification for its new CapnoPen technology
Capnopharm receives CE certification for its new CapnoPen technology

By IPP Bureau - May 31, 2023

Capnopharm’s new CapnoPen is the first PIPAC nebulizer to obtain CE marking under the new MDR regulation 2017/745

Ind-Swift Laboratories reports FY23 PAT at Rs. 42.47 Cr
Ind-Swift Laboratories reports FY23 PAT at Rs. 42.47 Cr

By IPP Bureau - May 30, 2023

The company reported lifetime high EBIDTA of Rs. 250 crores

Hikal posts FY23 PAT at Rs. 36 Cr
Hikal posts FY23 PAT at Rs. 36 Cr

By IPP Bureau - May 30, 2023

Pharmaceutical sales was flat and stood at Rs. 309 crore as compared to Rs. 308 crore in Q4 FY22

Jubilant Pharmova posts Q4FY23 consolidated loss at Rs. 97.84 Cr
Jubilant Pharmova posts Q4FY23 consolidated loss at Rs. 97.84 Cr

By IPP Bureau - May 30, 2023

The company has reported total income of Rs. 1682.45 crores during the period ended March 31, 2023

NATCO records FY23 PAT at Rs. 715.3 Cr
NATCO records FY23 PAT at Rs. 715.3 Cr

By IPP Bureau - May 30, 2023

The increase in revenue and profits for the year was driven by business growth in the US market and growth in our subsidiaries in Canada & Brazil.

SÜDPACK Medica and Liveo Research join forces at Connect in Pharma in Geneva
SÜDPACK Medica and Liveo Research join forces at Connect in Pharma in Geneva

By IPP Bureau - May 29, 2023

The PP-based top and bottom webs are manufactured in a unique coextrusion process

AiMeD applauds Govt. for launching 3 major Medical Device Policy & Scheme
AiMeD applauds Govt. for launching 3 major Medical Device Policy & Scheme

By IPP Bureau - May 29, 2023

Medical Device Policy is a progressive step in propelling the country towards Atmanirbharta in the heavily import dependent Medical Device Sector

Kristin Judge Joins Emmes as Chief Growth Officer
Kristin Judge Joins Emmes as Chief Growth Officer

By IPP Bureau - May 29, 2023

Wockhardt’s Q4 FY23 three fold jump in EBITDA over Q4 FY22
Wockhardt’s Q4 FY23 three fold jump in EBITDA over Q4 FY22

By IPP Bureau - May 29, 2023

Two patents were filed during the quarter ended 31st March, 2023 and the cumulative filings till date are 3239

Latest Stories

Interviews

Packaging